View of PLA2R-positive membranous nephropathy treated with rituximab (MENTOR regimen) in a patient with concomitant endometrial carcinoma

Return to Article Details PLA2R-positive membranous nephropathy treated with rituximab (MENTOR regimen) in a patient with concomitant endometrial carcinoma Download Download PDF